Leonard John E. 4/A
4/A · VACCINEX, INC. · Filed Sep 3, 2020
Insider Transaction Report
Form 4/AAmended
VACCINEX, INC.VCNX
Leonard John E.
SVP, Development
Transactions
- Exercise/Conversion
Common Stock
2020-07-14$3.90/sh+1,000$3,900→ 2,258 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-14−1,000→ 3,000 totalExercise: $3.90Exp: 2029-03-14→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.